Pharmaceuticals · Key players

Top Atopic Dermatitis Drugs companies

The 11 key players our Atopic Dermatitis Drugs report profiles, and other companies free public records show in this market.

Key players in Atopic Dermatitis Drugs

In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.

Key players in the Atopic Dermatitis Drugs market
#CompanyWebsiteOur reports
1 Sanofi sanofi.com (opens in a new tab) 1,386 reports
2 Pfizer Inc. pfizer.com (opens in a new tab) 2,310 reports
3 AbbVie Inc. abbvie.com (opens in a new tab) 1,254 reports
4 LEO Pharma A/S — 99 reports
5 Eli Lilly and Company lilly.com (opens in a new tab) 1,056 reports
6 Teva Pharmaceutical tevapharm.com (opens in a new tab) 462 reports
7 Novartis AG novartis.com (opens in a new tab) 1,551 reports
8 Regeneron Pharmaceuticals regeneron.com (opens in a new tab) 429 reports
9 Bristol-Myers Squibb bms.com (opens in a new tab) 627 reports
10 Galderma S.A. galderma.com (opens in a new tab) 297 reports
11 Dermira, Inc. dermira.com (opens in a new tab) 33 reports

Also active in Atopic Dermatitis Drugs

Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.

Also active in Atopic Dermatitis Drugs, from free public records
CompanyWhere public records show them
Hikma Pharmaceuticals PLC
Amneal Pharmaceuticals, Inc
Novitium Pharma
Keymed Biosciences Co.Ltd
PH Health
Almirall
Fresenius SE & CO
Mylan N.V.
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Jiangsu vcare pharmaceutical technology co., LTD
Zydus Lifesciences
Aurobindo Pharma

Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Source: Drugs@FDA, US approvals each company holds for medicines on the market whose FDA label lists this use. Retrieved 13 Nov 2026.

Top trial sponsors in Atopic Dermatitis Drugs

Companies leading the most active studies found with this market's trial search, worldwide (key players included).

  1. Sanofi 16 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Pfizer Inc. 14 active trials on ClinicalTrials.gov (opens in a new tab)
  3. AbbVie Inc. 9 active trials on ClinicalTrials.gov (opens in a new tab)
  4. Keymed Biosciences Co.Ltd 5 active trials on ClinicalTrials.gov (opens in a new tab)
  5. Almirall 4 active trials on ClinicalTrials.gov (opens in a new tab)
  6. Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 4 active trials on ClinicalTrials.gov (opens in a new tab)
  7. Jiangsu vcare pharmaceutical technology co., LTD 3 active trials on ClinicalTrials.gov (opens in a new tab)
  8. Qilu Pharmaceutical Co., Ltd. 3 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Atopic Dermatitis Drugs reports by place

All 33 places for Atopic Dermatitis Drugs

Get the full Atopic Dermatitis Drugs report

Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.

Buy the full report Request free sample

Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.